A serum protein electrophoresis test, commonly called SPEP, can flag a surprisingly wide range of diseases by separating the proteins in your blood into distinct groups and revealing abnormal patterns. It is best known for detecting blood cancers like multiple myeloma and their precursor conditions, but the same test can also point toward liver cirrhosis, chronic infections, autoimmune disorders, kidney disease, immune deficiencies, and even a genetic lung condition called alpha-1 antitrypsin deficiency. The power of SPEP lies not in diagnosing one specific illness but in generating recognizable protein patterns that narrow the diagnostic search considerably.
How the Test Works in Practice
SPEP works by placing a sample of your blood serum on a gel or through a capillary tube and applying an electrical current. Proteins migrate at different speeds depending on their size, shape, and electrical charge, eventually sorting themselves into five major bands: albumin, alpha-1 globulins, alpha-2 globulins, beta globulins, and gamma globulins.1PubMed. Understanding and interpreting serum protein electrophoresis Each band represents a family of proteins with different jobs. Albumin, the largest band, helps transport substances and maintain fluid balance. The alpha and beta bands contain proteins involved in inflammation, iron transport, and clotting. The gamma band holds your antibodies, also known as immunoglobulins.
A lab technician or pathologist then looks at the shape of the resulting graph. A healthy SPEP produces a predictable curve. When something is wrong, the curve changes in characteristic ways: a sharp spike in the gamma region, a flattened gamma band, a dip in albumin, or an unusual bridge between adjacent bands. Each of these distortions tells a different clinical story.
Multiple Myeloma and Related Plasma Cell Cancers
The disease most commonly associated with SPEP is multiple myeloma. In myeloma, a single clone of plasma cells in the bone marrow multiplies out of control and churns out large quantities of a single type of antibody or antibody fragment. This mass-produced protein shows up on SPEP as a tall, narrow spike in the gamma region, called an M-spike or monoclonal spike. In one study evaluating patients with suspected myeloma, the M-spike appeared in about two-thirds of cases tested.2Journal of Pathology of Nepal. Evaluation of serum protein electrophoresis in suspected cases of multiple myeloma Because the amount of monoclonal protein in the blood generally reflects the burden of cancer cells, SPEP is also used repeatedly during treatment to track whether therapy is working.
Waldenström macroglobulinemia is a related but distinct cancer where the malignant cells produce an IgM-type antibody rather than the IgG or IgA types more common in myeloma. SPEP can detect the M-spike in Waldenström patients, and accurate measurement of that spike is critical for evaluating their treatment response.3PubMed. Challenges with serum protein electrophoresis in assessing progression and clinical response in patients with Waldenström macroglobulinemia In one published case, SPEP revealed an elevated total protein level along with a clear IgM-kappa monoclonal spike, which ultimately helped distinguish the condition from classic myeloma.4PubMed Central. IgM Myeloma or Waldenstrom’s Macroglobulinemia Is the Big Question?
MGUS, the Premalignant Warning Sign
Not every M-spike means cancer. The most common cause of a monoclonal spike is a condition called monoclonal gammopathy of undetermined significance, or MGUS. It occurs in roughly 3% of people over 50 and involves a small population of abnormal plasma cells that produce a detectable M-protein without causing organ damage.5PubMed Central. Does My Patient with a Serum Monoclonal Spike have Multiple Myeloma? Think of MGUS as a precancerous state: most people with it never develop myeloma, but a small percentage progress each year, so lifelong monitoring is recommended.
Current guidelines suggest checking M-protein levels every six months for the first two years after a MGUS diagnosis. If the protein level stays stable (less than a 0.5 g/dL increase) and you remain symptom-free, follow-up testing can drop to once a year.6Mayo Clinic Laboratories. Monoclonal Protein Study, Quantitative, Serum This is one of the most practical outcomes of a SPEP finding: catching a condition years before it could become dangerous and keeping an eye on it with a straightforward blood test.
AL Amyloidosis and Where SPEP Falls Short
AL amyloidosis is a condition where abnormal light chain proteins, fragments of antibodies produced by clonal plasma cells, misfold and deposit in organs like the heart and kidneys. You might expect SPEP to catch it the same way it catches myeloma, but this is one of the test’s known blind spots. In AL amyloidosis, the clonal plasma cell population is often small, so the amount of abnormal protein produced can be minimal. Worse, the culprit proteins are frequently free light chains, which are smaller than whole antibodies and may migrate to unexpected positions on the electrophoresis strip rather than forming a clear gamma-region spike. An M-spike cannot be identified on SPEP in up to 30% of patients with AL amyloidosis.7PubMed Central. How to Screen for Monoclonal Gammopathy in Patients With a Suspected Amyloidosis
This is why amyloidosis workups almost always include additional tests, such as a serum free light chain assay and urine protein electrophoresis, alongside SPEP rather than relying on it alone.
Liver Cirrhosis
Liver disease produces one of the most recognizable SPEP patterns. In cirrhosis, the gamma globulin band rises and merges into the beta band, creating what is known as beta-gamma bridging. This fusion pattern is highly characteristic of cirrhosis and can be one of the first laboratory clues that liver scarring has become advanced.8PubMed. Serum proteins in hepatic disease The gamma increase is polyclonal, meaning it involves a broad rise in multiple antibody types rather than a single monoclonal spike. IgM levels tend to climb first, followed by IgG, while IgA elevation is less consistent.
Because albumin is made in the liver, the albumin band also drops as the liver loses function. The combination of low albumin and beta-gamma bridging on a single SPEP result is a strong prompt for further liver evaluation, even if the patient has not yet been investigated for cirrhosis.
Infections and Autoimmune Diseases
When your immune system ramps up against an infection or attacks your own tissues, many different plasma cells start producing antibodies at once. This produces a broad, dome-shaped elevation of the gamma band called polyclonal hypergammaglobulinemia, as opposed to the sharp, narrow M-spike of a single malignant clone. A French hospital study of 155 patients with this pattern found that infections were the most common underlying cause at 56%, followed by autoimmune and autoinflammatory diseases at 20%, liver diseases at 18%, and various malignancies at 6%.9PubMed Central. Etiological study of polyclonal hypergammaglobulinemia in a French cohort of hospitalized patients and proposal of a diagnostic aid algorithm
The infections driving this pattern ranged from bacterial sepsis and tuberculosis to acute hepatitis A and primary HIV infection. The autoimmune diseases were diverse, including lupus, Sjögren syndrome, vasculitis, sarcoidosis, and others.10Scientific Reports. Etiological study of polyclonal hypergammaglobulinemia in a French cohort of hospitalized patients and proposal of a diagnostic aid algorithm SPEP alone does not tell you which infection or autoimmune condition is responsible, but it narrows the field and often redirects the diagnostic workup toward inflammatory or infectious causes rather than malignancy.
Nephrotic Syndrome
Kidney diseases that cause heavy protein loss in the urine leave a distinctive footprint on SPEP. In nephrotic syndrome, albumin drops significantly because it leaks through damaged kidney filters. At the same time, the alpha-2 globulin fraction rises as the liver compensates by ramping up production of larger proteins that cannot escape through the kidneys as easily. Gamma globulins tend to fall as well, since antibodies are also lost in the urine.11Journal of Urology and Renal Diseases. The Role of Protein Electrophoresis in Differential Diagnosis of Renal Disorders This triad of low albumin, high alpha-2, and low gamma is one of the more reliable non-cancerous SPEP patterns and can push clinicians toward a kidney-focused evaluation when the cause of edema or protein loss is unclear.
Alpha-1 Antitrypsin Deficiency
Alpha-1 antitrypsin is a protein produced by the liver that protects your lungs from enzyme damage. People who inherit certain genetic mutations produce too little of it, leaving them vulnerable to early-onset emphysema and liver disease. This deficiency shows up on SPEP as a noticeably flattened or absent alpha-1 band, since alpha-1 antitrypsin is the dominant protein in that fraction.
A study using SPEP as an opportunistic screening tool identified low alpha-1 antitrypsin concentrations in about 0.3% of patients tested, and genetic analysis confirmed mutations in the SERPINA1 gene in the vast majority of those flagged.12PubMed Central. Utility of the Serum Protein Electrophoresis in the Opportunistic Screening for the Deficiency of Alpha-1 Antitrypsin Alpha-1 antitrypsin deficiency is underdiagnosed because its symptoms overlap with ordinary chronic obstructive pulmonary disease, and many clinicians do not think to test for it. SPEP can serve as an inexpensive early warning, even when the test was originally ordered for a completely different reason.
Immunodeficiency Disorders
Just as a high gamma band suggests the immune system is overactive, a very low or nearly absent gamma band suggests it is underperforming. The most common reason to see a flat gamma region on SPEP in an adult is hypogammaglobulinemia, meaning low antibody levels. One important condition in this category is common variable immunodeficiency, or CVID, a disorder in which the body fails to produce adequate immunoglobulins. Patients with CVID suffer recurrent infections, and the discovery of very low gamma globulin levels on SPEP is often the starting point for diagnosis.13PubMed Central. Are we forgetting to carry out serum protein electrophoresis as part of diagnosis workup?
Hypogammaglobulinemia can also result from medications that suppress the immune system, certain cancers like chronic lymphocytic leukemia, or heavy protein loss through the kidneys or gut. In each case, the flattened gamma band on SPEP serves as a clear visual flag that antibody levels deserve further measurement.
Complementary Tests That Fill SPEP’s Gaps
SPEP is a powerful screening tool, but it works best as part of a panel rather than in isolation. When an M-spike is detected, the next step is usually immunofixation electrophoresis, or IFE, which identifies the specific type of monoclonal protein involved. Knowing whether the spike is IgG, IgA, or IgM, and whether it involves kappa or lambda light chains, helps determine the exact diagnosis and guides treatment decisions.
Serum free light chain testing is another important companion test. Some plasma cell disorders, including a subset of myeloma cases, produce only free light chains rather than complete antibodies. These small proteins can slip through SPEP undetected, especially when their quantity is modest. In patients where SPEP shows no M-spike despite clinical suspicion of myeloma, free light chain analysis can reveal the abnormality.14PubMed Central. Can Serum Free Light Chains Be Used for the Early Diagnosis of Monoclonal Immunoglobulin-Secreting B-Cell and Plasma-Cell Diseases?
Urine protein electrophoresis, or UPEP, rounds out the standard workup for suspected myeloma. Light chains are small enough to pass through the kidney’s filtration system and appear in the urine. Roughly 15 to 20 percent of myeloma patients produce only light chains with no intact heavy chains in their blood, making urine testing essential for catching what SPEP might miss.
False Positives From Monoclonal Antibody Drugs
One increasingly common pitfall with SPEP involves modern cancer treatments. Drugs like daratumumab, which is itself a monoclonal antibody used to treat myeloma, can show up on SPEP as an artificial M-spike. When researchers added these drugs to serum from both healthy donors and myeloma patients, a visible and measurable M-protein appeared on SPEP, and immunofixation confirmed an IgG-kappa band, mimicking disease.15PubMed Central. Treatment of multiple myeloma with monoclonal antibodies and the dilemma of false positive M-spikes in peripheral blood For patients being monitored during treatment, this creates a real dilemma: is that residual M-spike the patient’s myeloma protein, or is it the drug? Labs have developed workarounds for this, but it is worth knowing about if you are a myeloma patient tracking your own SPEP results during therapy.
Why Reference Ranges Shift in Children
SPEP reference ranges were developed largely from adult populations, and applying them directly to children can lead to misinterpretation. A child’s immune system matures over years, and normal protein levels shift significantly with age. A study of pediatric SPEP patterns found that gamma globulin levels varied significantly across age groups, from infants under six months through children over seven years, with a statistically significant correlation between age and both total protein and beta globulin levels.16PubMed Central. Serum Protein Electrophoretic in Children A gamma globulin level that looks low in an adult might be perfectly normal in a six-month-old, whose maternal antibodies are waning while their own immune production is still ramping up. Pediatric SPEP interpretation requires age-adjusted reference ranges, and not all labs flag this clearly on their reports.
Modern Lab Methods and What They Changed
The traditional version of SPEP runs on agarose gel, with a technician visually inspecting stained protein bands. Over the past couple of decades, many labs have transitioned to capillary zone electrophoresis, or CZE, which automates the process and improves reproducibility.17PubMed. Comparison of serum protein electrophoresis by agarose gel and capillary zone electrophoresis in a clinical setting CZE produces a digital trace rather than a physical gel, making it easier to quantify protein fractions precisely and to archive results for comparison over time. For patients who need serial monitoring, such as those with MGUS or myeloma in remission, this consistency matters because even small changes in the M-spike can signal disease progression.
The switch to CZE has also improved detection of small monoclonal proteins that might be missed on a traditional gel. That said, no version of SPEP is a standalone diagnostic tool. The test identifies patterns that require interpretation and follow-up, not definitive diagnoses. A confirmed M-spike still needs immunofixation and clinical workup. A polyclonal rise in gamma globulins still requires investigation into its cause. SPEP is, at its core, a remarkably efficient screening test that points your doctor in the right direction and saves time that might otherwise be spent chasing less likely possibilities.